Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of January 2026
Jacob Miramar @Jacob Miramar
Platinum member since January 2017

Location: United States

Gender: Male

Asset investment style: Quantitative technical analysis

Market capitalization:

$8,138,874talents

Virtual portfolio value:

$5,211,088talents

Net overall return per annum:

19.97%

AYA current rank order:

#10

Asset investment philosophy:
Jacob Miramar trades U.S. stocks with the top #376 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
SXTP 60 Degrees Pharmaceuticals Inc. Common Stock $0.15 $1.34 141,773 +793.33% $168,710
VATE INNOVATE Corp. Common Stock $0.53 $4.14 40,124 +681.13% $144,848
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 2,827 +589.24% $116,105
XBIOW Xenetic Biosciences Inc. Warrants $2.00 $23.16 4,963 +1,058.00% $105,017
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 13,577 +2,108.33% $103,049
NTZ Natuzzi S.p.A. $2.21 $11.92 8,919 +439.37% $86,603
MPWR Monolithic Power Systems Inc. Common Stock $85.91 $392.24 229 +356.57% $70,150
TBLTW ToughBuilt Industries Inc. Warrant $0.09 $0.70 90,044 +677.78% $54,927
TUEM Tuesday Morning Corp. Common Stock $0.12 $0.69 79,200 +475.00% $45,144
MRNS Marinus Pharmaceuticals Inc. Common Stock $1.94 $11.62 2,827 +498.97% $27,365
Sum $921,918

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@Andy Yeh Alpha

Blog+More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More

Fed minutes reflect gradual interest rate normalization in response to high inflation risk.

Dan Rochefort

2018-02-15 07:43:00 Thursday ET

Fed minutes reflect gradual interest rate normalization in response to high inflation risk.

Fed minutes reflect gradual interest rate normalization in response to high inflation risk. FOMC members revise up the economic projections made at the Dece

+See More

Apple becomes the first company to hit $1 trillion stock market valuation.

Becky Berkman

2018-08-01 11:43:00 Wednesday ET

Apple becomes the first company to hit $1 trillion stock market valuation.

Apple becomes the first company to hit $1 trillion stock market valuation. The tech titan sells about the same number of smart phones or 41 million iPhones

+See More

U.K. prime minister Boris Johnson encounters Brexit defeat during his new premiership.

Chanel Holden

2019-10-15 09:13:00 Tuesday ET

U.K. prime minister Boris Johnson encounters Brexit defeat during his new premiership.

U.K. prime minister Boris Johnson encounters defeat during his new premiership. The first major vote would pave the path of least resistance to passing a no

+See More

The Chinese central bank has to circumvent offshore imports-driven inflation due to Renminbi currency misalignment.

Amy Hamilton

2019-07-07 18:36:00 Sunday ET

The Chinese central bank has to circumvent offshore imports-driven inflation due to Renminbi currency misalignment.

The Chinese central bank has to circumvent offshore imports-driven inflation due to Renminbi currency misalignment. Even though China keeps substantial fore

+See More

President Trump seeks to honor his campaign promise of lower U.S. medical costs by forcing higher big-pharma prices in foreign countries.

Charlene Vos

2018-05-07 07:32:00 Monday ET

President Trump seeks to honor his campaign promise of lower U.S. medical costs by forcing higher big-pharma prices in foreign countries.

President Trump seeks to honor his campaign promise of lower U.S. medical costs by forcing higher big-pharma prices in foreign countries such as Canada, Bri

+See More